Celia Belline is the founder of CILcare. CILcare has raised $43M in total funding. Latest round: Series A. Based in Montpellier, France.
Celia Belline is the co-founder and CEO of Cilcare, a French biotechnology company founded in 2014. Cilcare focuses on advancing diagnostics and therapeutics for hearing disorders such as cochlear synaptopathy and tinnitus, with a current focus on a Phase 2A clinical trial for SEAL-001.
Full founder directory · Investor directory · Company funding database · Fundraising library